Fundz

Milestone Pharmaceuticals Names Anthony Krick Vice President, Finance

PUBLIC · MISTNov 20, 2026
From SEC Form 3

Position

Vice President, Finance

Company

Milestone Pharmaceuticals

Anthony Krick
MontrealBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Anthony Krick became Vice President, Finance of Milestone Pharmaceuticals on November 10, 2026, per the SEC Form 3 filed November 19, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.

Quick answer

Milestone Pharmaceuticals Names Anthony Krick Vice President, Finance (November 20, 2026). Milestone Pharmaceuticals is based in Montreal, Quebec, Canada.

Who is the new Vice President, Finance at Milestone Pharmaceuticals?
Milestone Pharmaceuticals named Anthony Krick Vice President, Finance, announced November 20, 2026.
What did Milestone Pharmaceuticals announce on November 20, 2026?
Anthony Krick became Vice President, Finance of Milestone Pharmaceuticals on November 10, 2026, per the SEC Form 3 filed November 19, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
What does Milestone Pharmaceuticals do?
Thank you for your interest in Milestone Pharmaceuticals.
Where is Milestone Pharmaceuticals based?
Milestone Pharmaceuticals is based in Montreal, Quebec, Canada.
Which similar companies made leadership changes around the same time?
AbbVie Inc. (November 2, 2026), Retension Pharmaceuticals (October 23, 2026), Bristol Myers Squibb (November 15, 2026) and GH Research PLC (November 13, 2026) also announced leadership changes within 45 days of Milestone Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Milestone Pharmaceuticals, and when

A new leader at Milestone Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Milestone Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Milestone Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Milestone Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Milestone Pharmaceuticals

Location

Montreal, Quebec, Canada

About

Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur. Milestone is actively recruiting patients for a Phase 3 clinical trial of etripamil for the treatment of PSVT. Milestone plans to initiate a Phase 2 clinical trial in atrial fibrillation, another rapid heart rate condition, and expects to subsequently initiate an additional Phase 2 clinical trial in angina to establish proof-of-concept for the broader use of etripamil.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Milestone Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Joe
Likely contact at this company
••••••••@••••••••

See Joe's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Milestone Pharmaceuticals's next move

Learn about Strategic plan

Milestone Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.